학술논문

GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults
Document Type
Article
Source
In: Science Translational Medicine. (Science Translational Medicine, 12 January 2022, 14(627))
Subject
Language
English
ISSN
19466242
19466234